SCHEMBL19014719

SCHEMBL19014719

CC1(C)CCC(c2ccc(Cl)cc2)=C(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(N[C@H](CCNCCNCCP(=O)(O)O)CSc5ccccc5)c(S(=O)(=O)C(F)(F)F)c4)cc3)CC2)C1

nearest known ligand 0.82

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ BCL2L1 Q07817 18/20 0.82
▸ BCL2 P10415 17/20 0.82
▸ BAD Q92934 4/20 0.82
▸ BCL2L2 Q92843 3/20 0.82
▸ BCL2L11 O43521 1/20 0.82
▸ CYP2C9 P11712 1/20 0.82
▸ MCL1 Q07820 1/20 0.82
▸ ASPH Q12797 1/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29695619 0.95 BCL2L1 (0.86) BCL2L1BCL2BADBCL2L2BCL2L11
SCHEMBL21179210 0.95 BCL2L1 (0.86) BCL2L1BCL2BADBCL2L2BCL2L11
SCHEMBL21179208 0.95 BCL2L1 (0.86) BCL2L1BCL2BADBCL2L2BCL2L11
SCHEMBL19014705 0.94 BCL2L1 (0.89) BCL2L1BCL2BADBCL2L2BCL2L11
SCHEMBL19014891 0.93 BCL2L1 (0.88) BCL2L1BCL2BADBCL2L2BCL2L11
SCHEMBL19014619 0.92 BCL2L1 (0.80) BCL2L1BCL2BADBCL2L2BCL2L11
SCHEMBL22409418 0.92 BCL2L1 (0.82) BCL2L1BCL2BADBCL2L2BCL2L11
SCHEMBL22409460 0.92 BCL2L1 (0.89) BCL2L1BCL2BADBCL2L2BCL2L11
SCHEMBL19014632 0.92 BCL2L1 (0.89) BCL2L1BCL2BADBCL2L2BCL2L11
SCHEMBL20812412 0.91 BCL2L1 (0.87) BCL2L1BCL2BADBCL2L2BCL2L11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017101851-A1 ACYLSULFONAMIDE DERIVATIVES FOR TREATING SENESCENCE-ASSOCIATED DISEASES AND DISORDERS UNITY BIOTECHNOLOGY, INC. (US) 2017-06-22 — — WO disclosed
Send feedback